(Q40998688)

25 September 2017

1 reference

title

Hypothesis: compartmentalization of cytokines in intraabdominal infection (English)

1 reference

25 September 2017

Schein M

1

1 reference

25 September 2017

Wittmann DH

series ordinal

2

1 reference

25 September 2017

Holzheimer R

series ordinal

3

1 reference

25 September 2017

Condon RE

series ordinal

4

1 reference

25 September 2017

language of work or name

1 reference

1 June 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

119

1 reference

25 September 2017

issue

6

1 reference

25 September 2017

page(s)

694-700

1 reference

Pathogenetic mechanisms of septic shock

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Adjunctive therapy for septic shock: a review of experimental approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Strategies for blocking the systemic effects of cytokines in the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

The Complex Pattern of Cytokines in Sepsis Association Between Prostaglandins, Cachectin, and Interleukins

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Decreased tumor necrosis factor production during the initial stages of infection correlates with survival during murine gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Dynamics of blood components and peritoneal fluid during treatment of murine E. coli sepsis with beta-1,3-D-polyglucose derivatives. II. Interleukin 1, tumour necrosis factor, prostaglandin E2, and leukotriene B4.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Regulation of macrophage TNF alpha, IL-1 beta, and Ia (I-A alpha) mRNA expression during peritonitis is site dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Anti-tumor necrosis factor antibodies inhibit the influx of granulocytes and monocytes into an inflammatory exudate and enhance the growth of Listeria monocytogenes in various organs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Interleukin-1 alpha prevention of the lethality of Escherichia coli peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Pentoxifylline in the Treatment of Experimental Peritonitis in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Pathogenesis and prevention of adhesion formation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Tumour necrosis factor-mediated release of plasminogen activator inhibitor 1 by human peritoneal mesothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Long-term immunotherapeutic intervention with pentoxifylline in a mouse model of thermal injury and infection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Treatment of intra-abdominal infection with granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Granulocyte–macrophage colony-stimulating factor modulates immune function and improves survival after experimental thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Inflammatory fluids regulate TNF-alpha, but not IL-1 beta, production by human peritoneal macrophages. A study of patients on continuous ambulatory peritoneal dialysis with peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Plasma lnterleukin-6 Levels in Continuous Ambulatory Peritoneal Dialysis and Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Spontaneous bacterial peritonitis is associated with high levels of interleukin-6 and its secondary mediators in ascitic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

High levels of tumor necrosis factor-alpha and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Endotoxin, TNF-alpha, interleukin-6 and parameters of the cellular immune system in patients with intraabdominal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

D-erythro-neopterin plasma levels in intensive care patients with and without septic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Cytokines yes, cytokines no, cytokines maybe?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Sepsis and endotoxemia stimulate intestinal interleukin-6 production

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Systemic cytokine response after major surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

General stress response to conventional and laparoscopic cholecystectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Cefotaxime and metronidazole in severe intra-abdominal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Diagnostic and therapeutic challenges of intraabdominal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Five days of antibacterial therapy for bacterial meningitis in children?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Amniotic fluid interleukin-6: A sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Minimal antibiotic therapy after emergency abdominal surgery: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Tumor necrosis factor as the proximal mediator of sepsis--or this too will pass

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

An overview of mortality risk prediction in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Clinical relevance of antibiotic-induced endotoxin release

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

The biology of peritonitis and implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980195-4

7 January 2021

10.1016/S0039-6060(96)80195-4

Identifiers

DOI

1 reference

release_nqwayb3wgban7dxtasj6mukdfm

25 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nqwayb3wgban7dxtasj6mukdfm

24 November 2022

mapped directly with Wikidata item

1 reference